
NMPA Draft Clinical Guideline on Cardiac RF Ablation Devices – Implications for Boston Scientific, J&J, and Abbott
The NMPA released the “Draft Guideline on Clinical Evaluation for Cardiac Radiofrequency Ablation Devices” on July 2, 2026 for feedback. Feedbacks need to be submitted by July 30, 2026. The









